This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bostom, A. G. Articles by Selhub, J. Search for Related Content PubMed PubMed Citation Articles by Bostom, A. G. Articles by Selhub, J.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1894-1900.)
© 1997 American Heart Association, Inc.

Articles

Excess Prevalence of Fasting and Postmethionine-Loading Hyperhomocysteinemia in Stable Renal Transplant Recipients

Andrew G. Bostom; Reginald Y. Gohh; Michael Y. Tsai; Bette J. Hopkins-Garcia; Marie R. Nadeau; Lisa A. Bianchi; Paul F. Jacques; Irwin H. Rosenberg; ; Jacob Selhub

From the Jean Mayer USDA Human Nutrition Research Center at Tufts New England Medical Center, Boston, Mass (A.G.B., M.R.N., L.A.B., P.F.J., I.H.R., J.S.), Division of Renal Diseases and Transplant Services, Rhode Island Hospital, Providence, RI (R.Y.G., B.Y.H.-G.), Department of Laboratory Medicine and Pathology, University of Minnesota Hospital and Clinic, Minneapolis, Minn (M.Y.T.).

Correspondence and reprint requests to Dr. Andrew G. Bostom, Division of General Internal Medicine, Memorial Hospital of Rhode Island, 111 Brewster St, Pawtucket, RI 02860.

Abstract Hyperhomocysteinemia, either fasting or after methionine loading, may contribute to the increased incidence of cardiovascular disease events experienced by renal transplant recipients. Limited data are available on fasting homocysteine (Hcy) levels, and none on postmethionine-loading Hcy levels, in these patients. We assessed the prevalence and potential determinants of fasting and postmethionine-loading hyperhomocysteinemia in 29 stable renal transplant recipients and 58 age- and sex-matched, population-based controls free of renal disease with serum creatinine levels of 1.5 mg/dL or less. Total (t) plasma Hcy was determined fasting and 2 hours after methionine loading, along with fasting determinations of the B-vitamin cofactors/substrates for Hcy metabolism, ie, pyridoxal 5'-phosphate, B-12, and folate and serum creatinine. Geometric mean fasting (18.1 versus 9.8 µM, P<.001) and postmethionine-loading increase (22.0 versus 15.2, P=.001) in tHcy levels were significantly greater in the renal transplant recipients, as were the prevalence odds (with 95% confidence intervals) for fasting [14.8 (3.4-64.7)], postmethionine loading [6.9 (1.5-32.8)], combined fasting and postmethionine-loading [18.0 (2.3-142.1)] hyperhomocysteinemia, and inadequate circulating folate [4.2 (1.1-16.5)] or pyridoxal 5'-phosphate [3.2 (0.9-11.0) status. Correlation analyses suggested important potential relationships between creatinine and both fasting (+0.64, P<.001) and postmethionine-load increase (+0.38, P=.045) in tHcy, folate and fasting (-0.41, P=.025) tHcy, and pyridoxal 5'-phosphate and postmethionine-loading increase (-0.33, P=.091) in tHcy. We conclude that there is an excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients. Renal function is related to both fasting and postmethionine loading-hyperhomocysteinemia, inadequate folate status is associated with fasting hyperhomocysteinemia, and inadequate vitamin B-6 status may be related to postmethionine-loading hyperhomocysteinemia in this patient population.

Key Words: homocysteine • renal function • folate • vitamin B-6

This article has been cited by other articles:

				P. Villa, C. Perri, R. Suriano, F. Cucinelli, S. Panunzi, M. Ranieri, C. Mele, and A. Lanzone L-Folic Acid Supplementation in Healthy Postmenopausal Women: Effect on Homocysteine and Glycolipid Metabolism J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4622 - 4629. [Abstract] [Full Text] [PDF]

				D. Ducloux, G. Motte, N. U. Nguyen, A. Abdelfatah, R. Gibey, and J.-M. Chalopin Homocysteine, nutritional status and insulin in renal transplant recipients Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1674 - 1677. [Abstract] [Full Text] [PDF]

				O. Aras, M. Y. Tsai, N. Q. Hanson, R. Bailey, G. Rao, and D. B. Hunninghake Cystatin C Is an Independent Predictor of Fasting and Post-Methionine Load Total Homocysteine Concentrations among Stable Renal Transplant Recipients Clin. Chem., July 1, 2001; 47(7): 1263 - 1268. [Abstract] [Full Text] [PDF]

				M. E. Suliman, J. C. D. Filho, P. Barany, B. Anderstam, B. Lindholm, and J. Bergstrom Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients Nephrol. Dial. Transplant., January 1, 2001; 16(1): 102 - 110. [Abstract] [Full Text] [PDF]

				R. Diaz-Arrastia Homocysteine and Neurologic Disease Arch Neurol, October 1, 2000; 57(10): 1422 - 1427. [Abstract] [Full Text] [PDF]

				M. FÖDINGER, H. BUCHMAYER, G. HEINZ, M. PAPAGIANNOPOULOS, J. KLETZMAYR, S. RASOUL-ROCKENSCHAUB, W. H. HÖRL, and G. SUNDER-PLASSMANN Effect of MTHFR 1298A->C and MTHFR 677C->T Genotypes on Total Homocysteine, Folate, and Vitamin B12 Plasma Concentrations in Kdiney Graft Recipients J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1918 - 1925. [Abstract] [Full Text]

				B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER Recommendations for the Outpatient Surveillance of Renal Transplant Recipients J. Am. Soc. Nephrol., October 1, 2000; 11(2007): S1 - S86. [Abstract] [Full Text] [PDF]

				G. Stewart, A. G. Jardine, and J. D. Briggs Ischaemic heart disease following renal transplantation Nephrol. Dial. Transplant., February 1, 2000; 15(2): 269 - 277. [Full Text] [PDF]

				D. DUCLOUX, G. MOTTE, B. CHALLIER, R. GIBEY, and J.-M. CHALOPIN Serum Total Homocysteine and Cardiovascular Disease Occurrence in Chronic, Stable Renal Transplant Recipients: A ProspectiveStudy J. Am. Soc. Nephrol., January 1, 2000; 11(1): 134 - 137. [Abstract] [Full Text]

				A. J. Beaulieu, R. Y. Gohh, H. Han, D. Hakas, P. F. Jacques, J. Selhub, and A. G. Bostom Enhanced Reduction of Fasting Total Homocysteine Levels With Supraphysiological Versus Standard Multivitamin Dose Folic Acid Supplementation in Renal Transplant Recipients Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 2918 - 2921. [Abstract] [Full Text] [PDF]

				S. C. de Jong, C. D. A. Stehouwer, M. van den Berg, P. J. Kostense, D. Alders, C. Jakobs, G. Pals, and J. A. Rauwerda Determinants of Fasting and Post-Methionine Homocysteine Levels in Families Predisposed to Hyperhomocysteinemia and Premature Vascular Disease Arterioscler. Thromb. Vasc. Biol., May 1, 1999; 19(5): 1316 - 1324. [Abstract] [Full Text] [PDF]

				A. G. BOSTOM and B. F. CULLETON Hyperhomocysteinemia in Chronic Renal Disease J. Am. Soc. Nephrol., April 1, 1999; 10(4): 891 - 900. [Full Text]

				A. G. BOSTOM, R. Y. GOHH, L. BAUSSERMAN, D. HAKAS, P. F. JACQUES, J. SELHUB, L. DWORKIN, and I. H. ROSENBERG Serum Cystatin C as a Determinant of Fasting Total Homocysteine Levels in Renal Transplant Recipients with a Normal Serum Creatinine J. Am. Soc. Nephrol., January 1, 1999; 10(1): 164 - 166. [Abstract] [Full Text]

				D. E.C. Cole, H. J. Ross, J. Evrovski, L. J. Langman, S. E.S. Miner, P. A. Daly, and P.-Y. Wong Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients Clin. Chem., November 1, 1998; 44(11): 2307 - 2312. [Abstract] [Full Text] [PDF]